Clinical Trial Update: Serplulimab Combined With Cryoablation for Early-Stage Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating serplulimab in combination with cryoablation for early-stage non-small cell lung cancer; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Xi Junjie | Conditions: Early Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING